Another pharma giant makes a leap into the global medical marijuana business
Big Pharma just struck its second distribution deal with the growing global medical marijuana business.
Nine months after Novartis’ Sandoz group allied itself with Tilray, the medical cannabis grower Canndoc says it will use Teva’s SLE group to distribute its medical cannabis products in Israel, and then spearhead the global distribution of its products to markets around the world where medical cannabis is legal.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.